32 phenotypes from 5 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Mfngem1(IMPC)Ccpcz/Mfngem1(IMPC)Ccpcz C57BL/6NCrl-Mfngem1(IMPC)Ccpcz/Ccpcz	abnormal eye morphology	J:211773
	abnormal heart morphology	J:211773
	abnormal ovary morphology	J:211773
	abnormal skin morphology	J:211773
	abnormal spine curvature	J:211773
	abnormal thymus morphology	J:211773
	abnormal uterus morphology	J:211773
	decreased exploration in new environment	J:211773
	decreased locomotor activity	J:211773
	decreased NK T cell number	J:211773
	decreased startle reflex	J:211773
	enlarged heart	J:211773
	enlarged thymus	J:211773
	hydrometra	J:211773
	kyphosis	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	small testis	J:211773
Mfngtm1.1Cfg/Mfngtm1.1Cfg involves: C57BL/6	abnormal circulating enzyme level	J:217719
	decreased macrophage cell number	J:217719
	decreased mature B cell number	J:217719
	decreased neutrophil cell number	J:217719
	decreased partial thromboplastin time	J:217719
	decreased prothrombin time	J:217719
	increased B cell number	J:217719
	increased B cell proliferation	J:217719
	increased circulating factor IX level	J:217719
	increased circulating factor XI level	J:217719
	increased lymphocyte cell number	J:217719
Mfngtm1.1Heed/Mfngtm1.1Heed Not Specified	normal endocrine/exocrine gland phenotype	J:147764
	normal homeostasis/metabolism phenotype	J:147764
Mfngtm1Cjg/Mfngtm1Cjg B6.Cg-Mfngtm1Cjg	abnormal marginal zone B cell morphology	J:146621
Mfngtm1Seco/Mfngtm1Seco involves: 129P2/OlaHsd * C57BL/6J * FVB/N	no abnormal phenotype detected	J:149312